We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.84B
AUM Growth
-$535M
Cap. Flow
-$207M
Cap. Flow %
-3.54%
Top 10 Hldgs %
25.28%
Holding
175
New
17
Increased
89
Reduced
33
Closed
14

Top Buys

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$43.8M
2
NXT icon
Nextpower Inc
NXT
+$38.9M
3
NTNX icon
Nutanix
NTNX
+$36.8M
4
PWR icon
Quanta Services
PWR
+$33.4M
5
EVH icon
Evolent Health
EVH
+$28M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$165M
2
COUR icon
Coursera
COUR
+$63.3M
3
SPT icon
Sprout Social
SPT
+$57.1M
4
DLO icon
dLocal
DLO
+$49.4M
5
MDB icon
MongoDB
MDB
+$42.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.83%
2 Technology 24.9%
3 Industrials 17.52%
4 Consumer Discretionary 8.37%
5 Communication Services 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
76
Krystal Biotech
KRYS
$10.8B
$25.1M 0.43%
136,485
– –
BPMC
77
DELISTED
Blueprint Medicines
BPMC
$25M 0.43%
231,685
– –
AVB icon
78
AvalonBay Communities
AVB
$26.8B
$24.7M 0.42%
+119,178
New +$23M
PNR icon
79
Pentair
PNR
$10.6B
$24.4M 0.42%
318,119
+1,321
+0.4% +$106K
NTAP icon
80
NetApp
NTAP
$34.1B
$23.7M 0.41%
184,256
+78,752
+75% +$8.84M
VRSK icon
81
Verisk Analytics
VRSK
$26.1B
$22.9M 0.39%
85,138
+26,084
+44% +$6.38M
KROS icon
82
Keros Therapeutics
KROS
$202M
$22.8M 0.39%
499,208
-180,792
-27% -$9.71M
SO icon
83
Southern Company
SO
$106B
$22.6M 0.39%
291,413
+122,550
+73% +$9.29M
BHVN icon
84
Biohaven
BHVN
$2.08B
$22M 0.38%
634,664
+233,563
+58% +$9.24M
ESI icon
85
Element Solutions
ESI
$8.68B
$21.8M 0.37%
802,113
+64,198
+9% +$1.58M
WDAY icon
86
Workday
WDAY
$39B
$21.6M 0.37%
96,787
+2,236
+2% +$538K
UTHR icon
87
United Therapeutics
UTHR
$26.2B
$21.6M 0.37%
+67,825
New +$18M
ALNY icon
88
Alnylam Pharmaceuticals
ALNY
$27.4B
$21.1M 0.36%
87,000
– –
PEG icon
89
Public Service Enterprise Group
PEG
$38.6B
$21.1M 0.36%
286,296
+54,621
+24% +$3.88M
NOVT icon
90
Novanta
NOVT
$4.95B
$20.6M 0.35%
126,404
+45
+0% +$7.3K
CERE
91
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$20M 0.34%
490,000
– –
RPRX icon
92
Royalty Pharma
RPRX
$26.2B
$19.8M 0.34%
749,630
+58,943
+9% +$1.63M
MBLY icon
93
Mobileye
MBLY
$1.99B
$18.9M 0.32%
673,406
+42,027
+7% +$1.22M
FDMT icon
94
4D Molecular Therapeutics
FDMT
$526M
$18.5M 0.32%
881,157
+105,043
+14% +$2.64M
BBIO icon
95
BridgeBio Pharma
BBIO
$16.1B
$18.2M 0.31%
716,927
– –
KRRO icon
96
Korro Bio
KRRO
$151M
$17.9M 0.31%
529,155
-8,335
-2% -$461K
APTV icon
97
Aptiv
APTV
$12.3B
$17.7M 0.3%
250,781
+106
+0% +$8.15K
INZY
98
DELISTED
Inozyme Pharma
INZY
$17.6M 0.3%
3,936,220
+756,383
+24% +$3.67M
RCM
99
DELISTED
R1 RCM Inc. Common Stock
RCM
$17.3M 0.3%
1,375,980
– –
DYN icon
100
Dyne Therapeutics
DYN
$4.8B
$17.1M 0.29%
+485,000
New +$14.1M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Eventide Asset Management held 175 positions worth $5.84B, down 8.4% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $207M in Q2 2024, closing 14 positions and reducing 33 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Nextpower Inc worth $36.6M.

  • Eventide Asset Management's largest Q2 2024 buy was Nextpower Inc: 781,302 shares worth $36.6M.
  • Eventide Asset Management added most to Axsome Therapeutics in Q2 2024, an estimated $43.8M increase.
  • Eventide Asset Management's biggest Q2 2024 reduction was MongoDB, cutting an estimated $42.1M.
  • Eventide Asset Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.84B portfolio in Q2 2024.
  • Eventide Asset Management opened 17 new positions and closed 14 in Q2 2024.
  • Eventide Asset Management's portfolio value fell 8.4% quarter-over-quarter to $5.84B.

Based on Eventide Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.